Table 2:

Demographics and outcomes for those with SARS-CoV-2 infection in Alberta and Ontario by variant — Feb. 1, 2021, to June 30, 2021 (wave 3)

CharacteristicWild-typeAlpha variantDelta variantOther variantsNot tested/ indeterminateTotalp value
No. of people with a positive SARS-CoV-2 test92 427182 020370832 16448 760359 079
Age, yr, n (%)
 < 1819 884 (21.5)31 875 (17.5)702 (18.9)5439 (16.9)8449 (17.3)66 349 (18.5)< 0.0001
 18–3931 017 (33.6)69 101 (38.0)1409 (38.0)12 440 (38.7)18 944 (38.9)132 911 (37)
 40–6534 832 (37.7)67 697 (37.2)1290 (34.8)11 652 (36.2)16 551 (33.9)132 022 (36.8)
 > 656694 (7.2)13 347 (7.3)307 (8.3)2633 (8.2)4816 (9.9)27 797 (7.7)
Age, yr, median (IQR)
 Alberta32 (18–47)33 (20–47)32 (20–45)35 (22–48)NA33 (19–47)< 0.0001
 Ontario36 (23–54)36 (23–52)35 (22–52)36 (22–52)36 (22–53)36 (23–52)< 0.0001
Male, n (%)47 217 (51.1)92 315 (50.7)1898 (51.2)16 700 (51.9)24 492 (50.2)182 622 (50.9)< 0.0001
Rural resident, n (%)9317 (10.1)9856 (5.4)301 (8.1)1608 (5)3034 (6.2)24 116 (6.7)< 0.0001
Deprivation Index, n (%)
 Missing3902 (4.2)3231 (1.8)69 (1.9)482 (1.5)1243 (2.5)8927 (2.5)< 0.0001
 Q1 (least deprived)15 183 (16.4)32 650 (17.9)589 (15.9)5407 (16.8)8882 (18.2)62 711 (17.5)
 Q215 997 (17.3)34 327 (18.9)621 (16.7)5807 (18.1)8950 (18.4)65 702 (18.3)
 Q317 047 (18.4)34 328 (18.9)664 (17.9)6001 (18.7)8845 (18.1)66 885 (18.6)
 Q416 983 (18.4)36 044 (19.8)747 (20.1)6576 (20.4)9289 (19.1)69 639 (19.4)
 Q5 (most deprived)23 315 (25.2)41 440 (22.8)1018 (27.5)7891 (24.5)11 551 (23.7)85 215 (23.7)
In a long-term care facility, n (%)326 (0.4)165 (0.1)32 (0.9)53 (0.2)250 (0.5)826 (0.2)< 0.0001
Charlson Comorbidity Index score, n (%)
 0/missing87 775 (95)169 547 (93.1)3368 (90.8)29 602 (92)43 821 (89.9)334 113 (93)< 0.0001
 1943 (1)1475 (0.8)35 (0.9)263 (0.8)621 (1.3)3337 (0.9)
 2610 (0.7)1081 (0.6)29 (0.8)212 (0.7)402 (0.8)2334 (0.6)
 3+3099 (3.4)9917 (5.4)276 (7.4)2087 (6.5)3916 (8)19 295 (5.4)
Specific comorbidities, n (%)
 COPD or asthma360 (0.4)534 (0.3)7 (0.2)113 (0.4)193 (0.4)1207 (0.3)< 0.0001
 Other chronic lung disease (non-COPD/asthma)16 (0)23 (0)1–5*1–5*10 (0)56 (0)0.02
 Congestive heart failure331 (0.4)577 (0.3)12 (0.3)113 (0.4)242 (0.5)1275 (0.4)< 0.0001
 Hypertension1001 (1.1)1936 (1.1)46 (1.2)351 (1.1)719 (1.5)4053 (1.1)< 0.0001
 Diabetes mellitus1124 (1.2)1935 (1.1)52 (1.4)366 (1.1)754 (1.5)4231 (1.2)< 0.0001
 CAD (including previous MI, CABG or PCI/stent)443 (0.5)919 (0.5)22 (0.6)174 (0.5)343 (0.7)1901 (0.5)< 0.0001
 Peripheral vascular disease83 (0.1)147 (0.1)3 (0.1)36 (0.1)66 (0.1)335 (0.1)0.008
 Cerebrovascular disease (previous stroke/TIA)185 (0.2)312 (0.2)8 (0.2)54 (0.2)140 (0.3)699 (0.2)< 0.0001
 Atrial fibrillation/flutter330 (0.4)535 (0.3)18 (0.5)110 (0.3)263 (0.5)1256 (0.3)< 0.0001
 Ventricular arrhythmias31 (0)63 (0)1–5*17 (0.1)17 (0)130 (0)0.5
 Renal disease181 (0.2)348 (0.2)1–5*53 (0.2)139 (0.3)725 (0.2)0.0002
 Cancer417 (0.5)831 (0.5)18 (0.5)169 (0.5)317 (0.7)1752 (0.5)< 0.0001
 Peptic ulcer disease72 (0.1)124 (0.1)1–5*27 (0.1)55 (0.1)282 (0.1)0.04
 Liver disease173 (0.2)198 (0.1)8 (0.2)43 (0.1)122 (0.3)544 (0.2)< 0.0001
 Dementia181 (0.2)212 (0.1)9 (0.2)51 (0.2)168 (0.3)621 (0.2)< 0.0001
Vaccination status, n (%)
 Fully vaccinated334 (0.4)925 (0.5)111 (3)195 (0.6)935 (1.9)2500 (0.7)< 0.0001
 Partially vaccinated3823 (4.1)11 722 (6.4)1010 (27.2)2100 (6.5)3723 (7.6)22 378 (6.2)
 Unvaccinated88 270 (95.5)169 373 (93.1)2587 (69.8)29 869 (92.9)44 102 (90.4)334 201 (93.1)
Death
 Death within 30 days, n (%)532 (0.6)1384 (0.8)52 (1.4)325 (1)346 (0.7)2639 (0.7)< 0.0001
 Age at death, yr, median (IQR)
  Alberta75 (63–86)74 (65–85)72 (69–80)66 (56–73)NA74 (63–85)0.01
  Ontario79 (70–87)75 (65–84)73 (60–86)74 (65–84)78 (66–86)76 (66–85)< 0.0001
 Male, n (%)302 (56.8)822 (59.4)30 (57.7)202 (62.2)192 (55.5)1548 (58.7)< 0.0001
 Days to death, median (IQR)
  Alberta8 (3–14)9 (4–17)12 (4–18)9 (3–14)NA9 (4–15)0.4
  Ontario11 (6–17)12 (7–19)16 (11–21)13 (6–20)10 (4–16)12 (6–19)< 0.0001
All-cause hospitalization
 Hospital admission within 30 days3470 (3.8)11 552 (6.3)295 (8)2321 (7.2)2618 (5.4)20 256 (5.6)< 0.0001
 Age at hospitalization, yr, median (IQR)
  Alberta55 (38– 69)54 (41–66)57 (39–69)53 (40–62)NA54 (40–67)0.3
  Ontario63 (48–77)59 (46–71)57 (43–70)60 (48–72)61 (41–75)60 (46–73)< 0.0001
 Male, n (%)1878 (54.1)6284 (54.4)169 (57.3)1335 (57.5)1381 (52.8)11 047 (54.5)< 0.0001
 Length of stay, d, median (IQR)
  Alberta5 (3–10)5 (3–10)6 (3–10)6 (3–10)NA5 (3–10)0.8
  Ontario6 (3–11)6 (3–11)6 (3–11)7 (3–12)6 (2–11)6 (3–12)< 0.0001
  • Note: CABG = coronary artery bypass graft, CAD = coronary artery disease, COPD = chronic obstructive pulmonary disease, IQR = interquartile range, MI = myocardial infarction, NA = not available, PCI = percutaneous coronary intervention, TIA = transient ischemic attack.

  • * Cells with values of less than 5 have been suppressed for privacy reasons.